Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine PK in Pediatric Cardiac Surgery
NCT04685421Phase 1Terminated
- Sponsor
- Nicklaus Children's Hospital
- Start
- Jul 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bupivacaine in postoperative pain, sponsored by Nicklaus Children's Hospital. Primary endpoint: Bupivacaine-Exparel levels at 96 hours. Started Jul 2021; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04685421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04685421.